Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
about
Emollients and moisturisers for eczemaMechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitisDefects of corneocyte structural proteins and epidermal barrier in atopic dermatitisTh2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasisLocal rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trialLoss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge.Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.On the role of skin in the regulation of local and systemic steroidogenic activities.Role of the steroidogenic acute regulatory protein in health and disease.Prevention of atopic dermatitis.Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal α-toxin-induced keratinocyte deathLipid abnormalities and lipid-based repair strategies in atopic dermatitis.New approaches to the prevention of childhood atopic dermatitis.Skin barrier function in infancy: a systematic review.Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer.Emollients and moisturisers for eczema.Current Understanding in Pathogenesis of Atopic Dermatitis.Association between Stress and the HPA Axis in the Atopic Dermatitis.Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils.The practical understanding and treatment of asthma.IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.
P2860
Q24186075-1AEF4FA1-2323-47E5-A577-A9D8B2E25C2AQ26827984-E2CC37DF-BB0F-40EB-8EF1-CAE94D821FF7Q28085608-927A52FE-D0F0-4BFA-ABC2-3AB4C08C0F5FQ33916807-851D5B39-A29D-4644-9AAA-2BB2F1084D81Q34200863-3E3CCD9E-8C19-48DA-9538-EB16999545E6Q34353182-99FFD533-F1ED-43F6-BB4B-D5ECE6743016Q34658901-E8FBD183-2A90-42C3-ACB1-1D1FB47CEA99Q35305118-3CF2252A-634A-4CA1-A235-C83BBDB0684AQ36066892-6E4658F4-E165-4E2E-9577-6928B79D6E3AQ36244943-39ED7579-0BAD-4604-89EE-829D4187BFF9Q36447481-B728A031-7130-4E53-B385-A8D3FDD56C2FQ36449701-F1A61322-4B6B-482D-9633-9BAB191AC4B2Q36494773-A9DC2B28-5619-4E36-9C75-D92FE09EF23BQ37092236-5A7A261A-D589-41DD-B27A-5A9281985224Q38152889-FC03CA27-65F1-4AD2-9B86-2AD1BF03986BQ38174084-7D5CB13D-900C-4D4A-A094-69BEAF6F5422Q38193353-4906EEE3-F68C-4DE7-809D-5A4628835DCBQ38375544-4A791F50-B0B3-4B4F-B46B-7827150423F4Q38976344-38DDE583-BB30-4612-90FF-9CB5E76498DFQ41823296-CB5A8738-3AFF-4F5E-AE5B-896187BE91D6Q47167286-C9CF1350-85AB-4C9B-B632-FE4E222C4B5EQ47243988-B47864F4-BBC7-4580-9FE2-480299D51D71Q47572447-E0ED8250-D29A-45C0-B436-85C06AABA40FQ48247956-AF0D665B-36FF-46FE-9FB4-97C88E619AC8
P2860
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
@en
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
@nl
type
label
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
@en
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
@nl
prefLabel
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
@en
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
@nl
P2860
P1476
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
@en
P2093
Joan S Wakefield
Peter M Elias
P2860
P2888
P304
P356
10.1007/S12016-010-8231-1
P577
2011-12-01T00:00:00Z